New Key Statistics Module, Z-Score and F-Score
NAS:NAMS Key Ratios
Market Cap $ M | 1,710.29 |
Enterprise Value $ M | 1,280.15 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 4.42 |
Price/Sales | 481.56 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 3.00 |
EPS (TTM) $ | -2.62 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -12.08 |
EV-to-EBITDA | -12.08 |
PEG | -- |
Shares Outstanding M | 90.02 |
Net Margin (%) | -3,607.99 |
Operating Margin % | -2,880.08 |
Pre-tax Margin (%) | -3,607.99 |
Quick Ratio | 9.83 |
Current Ratio | 9.83 |
ROA % (ttm) | -29.60 |
ROE % (ttm) | -34.34 |
ROIC % (ttm) | -205.57 |
Dividend Yield % | -- |
Altman Z-Score | 15.77 |
NAMS Number of Guru Trades
NAMS Volume of Guru Trades
Gurus Latest Trades with NAS:NAMS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:NAMS is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NewAmsterdam Pharma Co NV Insider Transactions
No Available Data
News about NAS:NAMS
Total 0- 1